Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Bioventus (BVS) Accumulated Depreciation & Amortization (2020 - 2025)

Bioventus (BVS) has disclosed Accumulated Depreciation & Amortization for 6 consecutive years, with $5.7 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 25.16% year-over-year to $5.7 million, compared with a TTM value of $5.7 million through Dec 2025, down 25.16%, and an annual FY2025 reading of $5.7 million, down 25.16% over the prior year.
  • Accumulated Depreciation & Amortization was $5.7 million for Q4 2025 at Bioventus, up from $1.4 million in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $34.9 million in Q4 2021 and bottomed at $1.4 million in Q3 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $5.7 million, with a median of $2.7 million recorded in 2022.
  • The sharpest move saw Accumulated Depreciation & Amortization skyrocketed 368.81% in 2021, then crashed 72.05% in 2022.
  • Year by year, Accumulated Depreciation & Amortization stood at $34.9 million in 2021, then plummeted by 72.05% to $9.7 million in 2022, then decreased by 9.29% to $8.8 million in 2023, then dropped by 13.46% to $7.7 million in 2024, then decreased by 25.16% to $5.7 million in 2025.
  • Business Quant data shows Accumulated Depreciation & Amortization for BVS at $5.7 million in Q4 2025, $1.4 million in Q3 2025, and $1.4 million in Q2 2025.